Pharmacokinetics and bioavailability of danofloxacin in chukar partridge (Alectoris chukar) following intravenous, intramuscular, subcutaneous, and oral administrations

dc.authorid0000-0003-3168-2510
dc.authorid0000-0003-1567-991X
dc.authorid0000-0002-9017-763X
dc.authorid0000-0002-8674-4873
dc.contributor.authorÇorum, Orhan
dc.contributor.authorÇorum, Duygu Durna
dc.contributor.authorAtik, Orkun
dc.contributor.authorFakı, Hatice Eser
dc.contributor.authorAltan, Feray
dc.contributor.authorÜney, Kamil
dc.date.accessioned2020-03-26T20:19:07Z
dc.date.available2020-03-26T20:19:07Z
dc.date.issued2019
dc.departmentSelçuk Üniversitesi, Veteriner Fakültesi, Klinik Öncesi Bilimler Bölümüen_US
dc.description.abstractThe aim of the present study was to determine the pharmacokinetics (PKs) and bioavailability of danofloxacin in chukar partridge (Alectoris chukar) following intravenous (IV), intramuscular (IM), subcutaneous (SC), and oral (PO) administrations at a dose of 10 mg/kg. A total of eight clinically healthy chukar partridges weighing 480 +/- 45 g were used for the investigation. The study was performed in a crossover design (2 x 2 x 2 x 2) with a 15-day washout period between two administrations in four periods. The plasma concentrations of danofloxacin were determined using reversed-phase high-performance liquid chromatography. Noncompartmental PK parameters were also estimated. No local or systemic adverse drug effects were observed in any of the chukar partridges. The mean elimination half-life ranged between 8.18 and 12.08 hr and differed statistically among administration routes. The mean peak plasma concentrations of danofloxacin following IM, SC, and PO administrations were 8.05, 9.58, and 3.39 mu g/ml at 0.5, 1, and 4 hr, respectively. Following IM, SC, and PO administrations, the mean bioavailability was 86.33%, 134.40%, and 47.62%, respectively. The mean total clearance and volume of distribution at steady-state following IV administration were 0.13 L hr(-1) kg(-1) and 0.96 L/kg, respectively. These data, including favorable PKs and the absence of adverse drug effects, suggest that danofloxacin is a useful antibiotic in chukar partridges.en_US
dc.identifier.citationCorum, O., Durna Corum, D., Atik, O., Eser Faki, H., Altan, F., Uney, K. (2019). Pharmacokinetics and Bioavailability of Danofloxacin in Chukar Partridge (Alectoris chukar) Following Intravenous, Intramuscular, Subcutaneous, and Oral Administrations. Journal of Veterinary Pharmacology and Therapeutics, 42(2), 207-213.
dc.identifier.doi10.1111/jvp.12737en_US
dc.identifier.endpage213en_US
dc.identifier.issn0140-7783en_US
dc.identifier.issn1365-2885en_US
dc.identifier.issue2en_US
dc.identifier.pmid30474236en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage207en_US
dc.identifier.urihttps://dx.doi.org/10.1111/jvp.12737
dc.identifier.urihttps://hdl.handle.net/20.500.12395/38080
dc.identifier.volume42en_US
dc.identifier.wosWOS:000460077600009en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorUney, Kamil.
dc.language.isoenen_US
dc.publisherWILEYen_US
dc.relation.ispartofJOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICSen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectbioavailabilityen_US
dc.subjectchukar partridgeen_US
dc.subjectdanofloxacinen_US
dc.subjectpharmacokineticsen_US
dc.titlePharmacokinetics and bioavailability of danofloxacin in chukar partridge (Alectoris chukar) following intravenous, intramuscular, subcutaneous, and oral administrationsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Orhan CORUM.pdf
Boyut:
468.46 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Full Text Access